郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Activation of peripheral KCNQ channels relieves gout pain.

期刊:Pain发表年份:2015作者:Yueming Zheng; Haiyan Xu; Li Zhan; Xindi Zhou; Xueqin Chen; Zhaobing Gao

药效评价Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.

期刊:ACS chemical neuroscience发表年份:2015作者:Kimberly M Lovell; Kevin J Frankowski; Edward L Stahl; Stephen R Slauson; Euna Yoo; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn

药效评价3D-QSAR Based Pharmacophore Modeling and Virtual Screening for Identification of Novel G Protein-Coupled Receptor40 Agonists.

期刊:Current computer-aided drug design发表年份:2015作者:Peng Lu; Yubin Wang; PingKai Ouyang; Jinxiong She; Mingfang He

药效评价A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2015作者:Marcelo D Rosato-Siri; Erika Zambello; Chiara Mutinelli; Nicoletta Garbati; Roberto Benedetti; Laura Aldegheri; Francesca Graziani; Caterina Virginio; Giuseppe Alvaro; Charles H Large